Cyclo Therapeutics Inc (CYTH)
$0.61 $0.01 (1.06%) 12:05 PM 12/12/24
NASDAQ | $USD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$17.55M -
Day's Range
$0.60 - $0.62 -
Volume
26,124 -
52 Week Low / High
$0.59 - $2.12 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 0
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- $5.00
- Target Price
Company News
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. — Dec 27th, 2023
Combined company operating as Cyclo Therapeutics with primary focus on advancing Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) Cash runway extended into 2H 2024 with approximately $11.0 million cash on hand to fund operations GAINESVILLE, Fla., December 27,...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
-
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer — Oct 21st, 2024
Pacira BioSciences Seasoned Executive Brings More Than 25 Years of Global Financial and Operational Biopharmaceutical Leadership Experience TAMPA, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioi...
Similar Stocks
Portfolio
Comprised of 1 portfolios